CN101563613A - 借助抗利尿激素原、特别是和肽素或ⅱ型后叶激素运载蛋白对呼吸道和肺部的感染及慢性病的诊断和风险性分级 - Google Patents

借助抗利尿激素原、特别是和肽素或ⅱ型后叶激素运载蛋白对呼吸道和肺部的感染及慢性病的诊断和风险性分级 Download PDF

Info

Publication number
CN101563613A
CN101563613A CNA2007800420148A CN200780042014A CN101563613A CN 101563613 A CN101563613 A CN 101563613A CN A2007800420148 A CNA2007800420148 A CN A2007800420148A CN 200780042014 A CN200780042014 A CN 200780042014A CN 101563613 A CN101563613 A CN 101563613A
Authority
CN
China
Prior art keywords
respiratory tract
infection
disease
lung
diagnosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800420148A
Other languages
English (en)
Chinese (zh)
Inventor
A·博格曼
N·莫根塔勒
J·帕帕索提里奥
J·斯塔克
B·穆勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRAHMS GmbH
Original Assignee
BRAHMS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRAHMS GmbH filed Critical BRAHMS GmbH
Priority to CN201510454116.7A priority Critical patent/CN105092858A/zh
Publication of CN101563613A publication Critical patent/CN101563613A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2007800420148A 2006-11-12 2007-11-11 借助抗利尿激素原、特别是和肽素或ⅱ型后叶激素运载蛋白对呼吸道和肺部的感染及慢性病的诊断和风险性分级 Pending CN101563613A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510454116.7A CN105092858A (zh) 2006-11-12 2007-11-11 借助抗利尿激素原对呼吸道和肺部的感染及慢性病的诊断和风险性分级

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006053442A DE102006053442A1 (de) 2006-11-12 2006-11-12 Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II
DE102006053442.5 2006-11-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510454116.7A Division CN105092858A (zh) 2006-11-12 2007-11-11 借助抗利尿激素原对呼吸道和肺部的感染及慢性病的诊断和风险性分级

Publications (1)

Publication Number Publication Date
CN101563613A true CN101563613A (zh) 2009-10-21

Family

ID=39277664

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201510454116.7A Pending CN105092858A (zh) 2006-11-12 2007-11-11 借助抗利尿激素原对呼吸道和肺部的感染及慢性病的诊断和风险性分级
CNA2007800420148A Pending CN101563613A (zh) 2006-11-12 2007-11-11 借助抗利尿激素原、特别是和肽素或ⅱ型后叶激素运载蛋白对呼吸道和肺部的感染及慢性病的诊断和风险性分级

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201510454116.7A Pending CN105092858A (zh) 2006-11-12 2007-11-11 借助抗利尿激素原对呼吸道和肺部的感染及慢性病的诊断和风险性分级

Country Status (10)

Country Link
US (3) US8158368B2 (enExample)
EP (2) EP2378290B1 (enExample)
JP (3) JP5340160B2 (enExample)
CN (2) CN105092858A (enExample)
AT (1) ATE522814T1 (enExample)
DE (1) DE102006053442A1 (enExample)
DK (1) DK2378290T3 (enExample)
ES (2) ES2634137T3 (enExample)
HK (1) HK1215731A1 (enExample)
WO (1) WO2008058517A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104126125A (zh) * 2012-03-08 2014-10-29 B.R.A.H.M.S有限公司 慢性阻塞性肺疾病患者的结果的预测

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140046407A1 (en) * 2001-08-31 2014-02-13 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
EP1628136A1 (en) * 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
PL2084543T3 (pl) * 2006-10-26 2018-04-30 B.R.A.H.M.S Gmbh Stratyfikacja ryzyka ostrego zespołu wieńcowego za pomocą fragmentów/ częściowych peptydów prowazopresyny, a zwłaszcza kopeptyny lub neurofizyny II
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
US20120329666A1 (en) * 2009-10-05 2012-12-27 Duke University Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia and Methods of Use
EP2776064A4 (en) * 2011-11-11 2015-08-05 Woomera Therapeutics ANTAGONISTS OF PRO-VASOPRESSIN AND USES THEREOF
KR102511128B1 (ko) 2022-03-31 2023-03-16 (주)네오닉스 배터리팩

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227454C1 (de) 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
EP1111050B1 (de) 1999-12-22 2007-03-14 Dade Behring Marburg GmbH Lösungen von humanem Procalcitonin
DE10027954A1 (de) 1999-12-22 2001-06-28 Dade Behring Marburg Gmbh Humanes Procalcitonin, dessen Herstellung und Verwendung
MXPA03004105A (es) * 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
EP1539818B1 (en) * 2002-07-16 2010-12-15 Woomera Therapeutics, Inc. Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
JP2006526140A (ja) * 2002-12-24 2006-11-16 バイオサイト インコーポレイテッド 鑑別診断のためのマーカーおよびその使用方法
GB0401730D0 (en) * 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
EP1628136A1 (en) * 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
DE102004047968A1 (de) * 2004-10-01 2006-04-06 B.R.A.H.M.S Ag Bestimmung von Gastrokine 1 (GKN1) als Biomarker für Entzündungen und Infektionen
GB0508863D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Peptide
DE102007021443A1 (de) * 2007-05-08 2008-11-13 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels NT-proET-1
JP4983525B2 (ja) * 2007-10-11 2012-07-25 住友電装株式会社 ワイヤハーネスのプロテクタ取付構造
ES2643033T3 (es) * 2009-05-05 2017-11-21 B.R.A.H.M.S Gmbh Estratificación basada en la hormona vasoactiva de los pacientes que sufren de enfermedades relacionadas con la función/disfunción endotelial

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104126125A (zh) * 2012-03-08 2014-10-29 B.R.A.H.M.S有限公司 慢性阻塞性肺疾病患者的结果的预测
CN104126125B (zh) * 2012-03-08 2017-03-01 B.R.A.H.M.S有限公司 慢性阻塞性肺疾病患者的结果的预测

Also Published As

Publication number Publication date
US20170059583A1 (en) 2017-03-02
ES2634137T3 (es) 2017-09-26
JP2010509576A (ja) 2010-03-25
DK2378290T3 (en) 2017-07-31
US8158368B2 (en) 2012-04-17
JP2016026286A (ja) 2016-02-12
WO2008058517A3 (de) 2008-10-23
HK1215731A1 (zh) 2016-09-09
EP2089718A2 (de) 2009-08-19
US10718783B2 (en) 2020-07-21
US20120270245A1 (en) 2012-10-25
EP2378290B1 (de) 2017-05-03
JP6170101B2 (ja) 2017-07-26
JP2013083664A (ja) 2013-05-09
JP5340160B2 (ja) 2013-11-13
ATE522814T1 (de) 2011-09-15
CN105092858A (zh) 2015-11-25
DE102006053442A1 (de) 2008-05-15
EP2378290A1 (de) 2011-10-19
US20100041064A1 (en) 2010-02-18
ES2370071T3 (es) 2011-12-12
WO2008058517A2 (de) 2008-05-22
EP2089718B1 (de) 2011-08-31

Similar Documents

Publication Publication Date Title
US8465941B2 (en) Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure
JP6170101B2 (ja) プロバソプレシン、特にコペプチンもしくはニューロフィジンｉｉによる、気道および肺の感染および慢性疾患の診断および／または危険性の層化
EP2300829B1 (en) New biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
ES2944613T3 (es) proADM y/o histonas como marcadores indicadores de un acontecimiento adverso
Travaglino et al. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial
CN101194167A (zh) NT-proANP和NT-proBNP用于诊断心脏病的用途
EP2227696A1 (en) Means and methods for assessing the risk of patients presenting to emergency units based on gdf-15
TW201439122A (zh) 膀胱及腎臟癌之尿液生物標記及其應用
HK1135183A (en) Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin ii
JP2022534034A (ja) ＨＦｐＥＦのためのＩＧＦＢＰ７の比
ES2807960T3 (es) Método para diagnosticar infecciones pulmonares postoperatorias en pacientes que se sometieron a cirugía
RU2775090C2 (ru) Проадреномедуллин в качестве маркера, указывающего на неблагоприятное событие
HK1137807B (en) Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure
WO2025241863A1 (zh) Gsdmd在胸痛相关疾病诊断及疗效评估上的用途
HK1177963A1 (zh) 在无症状患者中基於il-6检测的全身炎性应答综合徵和败血症的早期诊断和预测
HK1177963B (en) Il-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1135183

Country of ref document: HK

C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: German Hennings Dov

Applicant after: BRAHMS AG

Address before: German Hennings Dov

Applicant before: Brahms AG

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: BRAHMS AG TO: BRAHMS CO., LTD.

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20091021

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1135183

Country of ref document: HK